- Home
- AIM vs TWG Comparison
AIM vs TWG Comparison
Compare AIM & TWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIM
- TWG
- Stock Information
- Founded
- AIM 1966
- TWG 2009
- Country
- AIM United States
- TWG Hong Kong
- Employees
- AIM N/A
- TWG 12
- Industry
- AIM Biotechnology: Biological Products (No Diagnostic Substances)
- TWG
- Sector
- AIM Health Care
- TWG
- Exchange
- AIM Nasdaq
- TWG NYSE
- Market Cap
- AIM 15.9M
- TWG 11.1M
- IPO Year
- AIM N/A
- TWG 2024
- Fundamental
- Price
- AIM $0.20
- TWG $0.21
- Analyst Decision
- AIM Strong Buy
- TWG
- Analyst Count
- AIM 2
- TWG 0
- Target Price
- AIM $2.75
- TWG N/A
- AVG Volume (30 Days)
- AIM 403.8K
- TWG 1.7M
- Earning Date
- AIM 11-15-2024
- TWG 02-15-2025
- Dividend Yield
- AIM N/A
- TWG N/A
- EPS Growth
- AIM N/A
- TWG 27.13
- EPS
- AIM N/A
- TWG 0.09
- Revenue
- AIM $190,000.00
- TWG $16,943,287.00
- Revenue This Year
- AIM N/A
- TWG N/A
- Revenue Next Year
- AIM $1,086.80
- TWG N/A
- P/E Ratio
- AIM N/A
- TWG $2.44
- Revenue Growth
- AIM N/A
- TWG 99.03
- 52 Week Low
- AIM $0.16
- TWG $0.17
- 52 Week High
- AIM $0.62
- TWG $13.50
- Technical
- Relative Strength Index (RSI)
- AIM 40.44
- TWG N/A
- Support Level
- AIM $0.20
- TWG N/A
- Resistance Level
- AIM $0.23
- TWG N/A
- Average True Range (ATR)
- AIM 0.02
- TWG 0.00
- MACD
- AIM 0.00
- TWG 0.00
- Stochastic Oscillator
- AIM 10.75
- TWG 0.00
About AIM AIM ImmunoTech Inc.
AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders and viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases, and the drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer, and triple-negative metastatic breast cancer. It is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19.
About TWG TOP WEALTH GROUP HLDG LTD
Top Wealth Group Holding Ltd is as supplier of caviar and offer caviar-based gourmet products. It is specialized in supplying high quality sturgeons caviar.